Found 7 matching trials
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) PHASE3 This study is designed to evaluate whether asenapine, which is approved by ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) PHASE1 This study is an open label, sequential-group, two site, multiple dose esca...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) PHASE3 The purpose of this trial is to assess the effect of asenapine 2.5 and 5 mg...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) PHASE3 Participants who have completed the 6-week trial P05688 can be screened for...
Show More Location
Forest Investigative Site 2001
Learn More & Join Trial
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) PHASE3 Efficacy and safety of asenapine for the treatment of bipolar I disorder (m...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) PHASE3 This study will investigate the safety and tolerability of a flexible dosin...
Show More Location
Multiple Locations
Learn More & Join Trial
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) PHASE3 This study is designed to evaluate whether asenapine, which is approved by ...
Show More Location
Multiple Locations
Learn More & Join Trial